Orthocell Ltd
OCC
Company Profile
Business description
Orthocell Ltd is engaged in the development, manufacture and commercialisation of collagen-based medical devices and cell therapies for the repair and regeneration of bone, nerve, tendon and cartilage defects. It has one segment regenerative medicine industry in Australia with products sold in Australia and internationally. Its solutions are Remplier, Striate, and Cell Therapies.
Contact
161 Campus Drive
Level 2, Murdoch University
Murdoch
PerthWA6150
AUST: +61 893602888
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
Employees
Stocks News & Analysis
stocks
What did Morningstar subscribers buy and sell during August?
Earnings season fuels trading activity.
stocks
Tesla: Shares fall as market disappointed with Cybercab launch event
We think Tesla stock is fairly valued.
stocks
The best global tech stocks to buy
These 12 undervalued technology stocks look attractive today.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,967.50 | 64.00 | -0.71% |
| CAC 40 | 8,156.67 | 161.31 | -1.94% |
| DAX 40 | 25,576.45 | 431.18 | -1.66% |
| Dow JONES (US) | 52,380.66 | 405.41 | -0.77% |
| FTSE 100 | 10,670.06 | 141.60 | -1.31% |
| HKSE | 24,939.15 | 335.81 | -1.33% |
| NASDAQ | 26,253.34 | 168.07 | -0.64% |
| Nikkei 225 | 64,700.43 | 442.35 | -0.68% |
| NZX 50 Index | 13,716.76 | 102.67 | -0.74% |
| S&P 500 | 7,636.36 | 37.16 | -0.48% |
| S&P/ASX 200 | 8,775.90 | 62.10 | -0.70% |
| SSE Composite Index | 3,937.78 | 13.73 | -0.35% |